{"id":2600,"date":"2018-02-23T12:54:04","date_gmt":"2018-02-23T12:54:04","guid":{"rendered":"https:\/\/lynxee.consulting\/?p=2600\/"},"modified":"2025-07-21T12:58:18","modified_gmt":"2025-07-21T12:58:18","slug":"europe-allocation-of-ms-for-air4-and-air5-active-substances","status":"publish","type":"post","link":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/","title":{"rendered":"EUROPE: Allocation of MS for AIR4 and AIR5 active substances"},"content":{"rendered":"<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Regulation (EU) 686\/2012 indicates for each active substance a rapporteur member state (RMS) and a co-rapporteur member state (cRMS) that have been allocated for the renewal procedure.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">AIR4 active substances are substances whose approval expires after 31 December 2018 and not later than 31 December 2021. In view of the length of the evaluation process and the recent notification by the United Kingdom pursuant to Article 50 of the Treaty on European Union, it was necessary to re-allocate the evaluation of the active substances for which the United Kingdom was the RMS or the cRMS, and for which no supplementary dossier had been submitted yet. The updates set by Regulation (EU) 2018\/155 concern the following active substances: Aluminium ammonium sulphate, Azoxystrobin, Bupirimate, Carbetamide, Chlormequat, Ethylene, Fenbuconazole, Fluopicolide, Fluquinconazole, Flutriafol, Garlic extract, Metazachlor, Myclobutanil, Paclobutrazol, Pepper, Plant oils\/Citronella oil, Propaquizafop, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Tri-allate and Urea.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">AIR5 active substances are substances whose approval expires after 31 December 2021 and not later than 31 December 2024 and for which the evaluation had not been allocated yet. The allocation of RMS and cRMS is set by Regulation (EU) 2018\/155 for each AIR5 active substance.<\/span><\/p>\n<p style=\"text-align: justify;\"><b><br \/>\nTo download: \u00a0<\/b><\/p>\n<p style=\"text-align: justify;\"><a href=\"http:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32018R0155&amp;from=FR\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">COMMISSION IMPLEMENTING REGULATION (EU) 2018\/155 of 31 January 2018 amending Implementing Regulation (EU) No 686\/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances <\/span><\/a><\/p>\n<p style=\"text-align: justify;\"><b><br \/>\nLynxee consulting<\/b><span style=\"font-weight: 400;\">\u2019s team is at your disposal to answer your questions.<\/span><\/p>\n<p><b>Contact us!<\/b> <a href=\"https:\/\/lynxee.consulting\/en\/contact\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">https:\/\/lynxee.consulting\/en\/contact\/<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6>Photo credit: InspiredImages\/pixabay<\/h6>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regulation (EU) 686\/2012 indicates for each active substance a rapporteur member state (RMS) and a co-rapporteur member state (cRMS) that have been allocated for the renewal<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":4,"featured_media":8436,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[150,231],"class_list":["post-2600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulation","tag-air4-en","tag-air5-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EUROPE: Allocation of MS for AIR4 and AIR5 active substances - Lynxee consulting<\/title>\n<meta name=\"description\" content=\"Regulation (EU) 686\/2012 indicates for each active substance a rapporteur member state (RMS) and a co-rapporteur member state (cRMS) that have been\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EUROPE: Allocation of MS for AIR4 and AIR5 active substances - Lynxee consulting\" \/>\n<meta property=\"og:description\" content=\"Regulation (EU) 686\/2012 indicates for each active substance a rapporteur member state (RMS) and a co-rapporteur member state (cRMS) that have been\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/\" \/>\n<meta property=\"og:site_name\" content=\"Lynxee consulting\" \/>\n<meta property=\"article:published_time\" content=\"2018-02-23T12:54:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-21T12:58:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/03\/winter-843578_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1355\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Vianay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Vianay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/\"},\"author\":{\"name\":\"\u00c9milie Vianay\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\"},\"headline\":\"EUROPE: Allocation of MS for AIR4 and AIR5 active substances\",\"datePublished\":\"2018-02-23T12:54:04+00:00\",\"dateModified\":\"2025-07-21T12:58:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/\"},\"wordCount\":244,\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/winter-843578_1920.jpg\",\"keywords\":[\"AIR4\",\"AIR5\"],\"articleSection\":[\"Regulation\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/\",\"name\":\"EUROPE: Allocation of MS for AIR4 and AIR5 active substances - Lynxee consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/winter-843578_1920.jpg\",\"datePublished\":\"2018-02-23T12:54:04+00:00\",\"dateModified\":\"2025-07-21T12:58:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\"},\"description\":\"Regulation (EU) 686\\\/2012 indicates for each active substance a rapporteur member state (RMS) and a co-rapporteur member state (cRMS) that have been\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/winter-843578_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/winter-843578_1920.jpg\",\"width\":1920,\"height\":1355},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-allocation-of-ms-for-air4-and-air5-active-substances\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EUROPE: Allocation of MS for AIR4 and AIR5 active substances\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/\",\"name\":\"Lynxee consulting\",\"description\":\"Innovative support for regulatory issues\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lynxee.consulting\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\",\"name\":\"\u00c9milie Vianay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"caption\":\"\u00c9milie Vianay\"},\"sameAs\":[\"https:\\\/\\\/lynxee.consulting\"],\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/author\\\/emilie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EUROPE: Allocation of MS for AIR4 and AIR5 active substances - Lynxee consulting","description":"Regulation (EU) 686\/2012 indicates for each active substance a rapporteur member state (RMS) and a co-rapporteur member state (cRMS) that have been","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/","og_locale":"en_US","og_type":"article","og_title":"EUROPE: Allocation of MS for AIR4 and AIR5 active substances - Lynxee consulting","og_description":"Regulation (EU) 686\/2012 indicates for each active substance a rapporteur member state (RMS) and a co-rapporteur member state (cRMS) that have been","og_url":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/","og_site_name":"Lynxee consulting","article_published_time":"2018-02-23T12:54:04+00:00","article_modified_time":"2025-07-21T12:58:18+00:00","og_image":[{"width":1920,"height":1355,"url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/03\/winter-843578_1920.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Vianay","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Vianay","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/#article","isPartOf":{"@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/"},"author":{"name":"\u00c9milie Vianay","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d"},"headline":"EUROPE: Allocation of MS for AIR4 and AIR5 active substances","datePublished":"2018-02-23T12:54:04+00:00","dateModified":"2025-07-21T12:58:18+00:00","mainEntityOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/"},"wordCount":244,"image":{"@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/03\/winter-843578_1920.jpg","keywords":["AIR4","AIR5"],"articleSection":["Regulation"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/","url":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/","name":"EUROPE: Allocation of MS for AIR4 and AIR5 active substances - Lynxee consulting","isPartOf":{"@id":"https:\/\/lynxee.consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/#primaryimage"},"image":{"@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/03\/winter-843578_1920.jpg","datePublished":"2018-02-23T12:54:04+00:00","dateModified":"2025-07-21T12:58:18+00:00","author":{"@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d"},"description":"Regulation (EU) 686\/2012 indicates for each active substance a rapporteur member state (RMS) and a co-rapporteur member state (cRMS) that have been","breadcrumb":{"@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/#primaryimage","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/03\/winter-843578_1920.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/03\/winter-843578_1920.jpg","width":1920,"height":1355},{"@type":"BreadcrumbList","@id":"https:\/\/lynxee.consulting\/en\/europe-allocation-of-ms-for-air4-and-air5-active-substances\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lynxee.consulting\/en\/"},{"@type":"ListItem","position":2,"name":"EUROPE: Allocation of MS for AIR4 and AIR5 active substances"}]},{"@type":"WebSite","@id":"https:\/\/lynxee.consulting\/#website","url":"https:\/\/lynxee.consulting\/","name":"Lynxee consulting","description":"Innovative support for regulatory issues","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lynxee.consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d","name":"\u00c9milie Vianay","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","caption":"\u00c9milie Vianay"},"sameAs":["https:\/\/lynxee.consulting"],"url":"https:\/\/lynxee.consulting\/en\/author\/emilie\/"}]}},"_links":{"self":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/comments?post=2600"}],"version-history":[{"count":4,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2600\/revisions"}],"predecessor-version":[{"id":8440,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2600\/revisions\/8440"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media\/8436"}],"wp:attachment":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media?parent=2600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/categories?post=2600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/tags?post=2600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}